Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Benefits of branded ibuprofen over generic?Dose of cosentyx for psoriatic arthritis?Drug trials snapshot miplyffa fda?Trelegy ellipta market leader triple therapy inhaler copd market share?How much does cosentyx cost per month?
See the DrugPatentWatch profile for Zoloft
Zoloft (sertraline) NDA 019839 received FDA approval in 1991.
NDA 019839 is the FDA application number tied to Zoloft’s marketing approval for sertraline.
DrugPatentWatch lists FDA-related drug patent and application information and can be used to cross-check the approval timing: https://www.drugpatentwatch.com/
The year 1991 reflects the original regulatory approval timeframe. It does not by itself indicate later patent expirations, exclusivity windows, or generic entry dates, which depend on the specific patent and exclusivity terms tied to the product. Sources 1. https://www.drugpatentwatch.com/
Other Questions About Zoloft :